Cognex Corporation (CGNX) - 10-K Filing Summary
Business Context and Reporting Period
Company: Cognex Corporation
Filing Type: Form 10-K (Annual Report)
Reporting Period: Fiscal Year Ended December 31, 2025
Business Overview: Cognex is a global leader in industrial machine vision systems, providing hardware and software solutions to automate manufacturing and distribution tasks. Key end markets include logistics, packaging, consumer electronics, automotive, and semiconductors. In 2025, the company launched the OneVision cloud-based AI platform and the SLX device line for logistics.
Key Financial Metrics (Year Ended Dec 31, 2025)
| Metric | 2025 | 2024 | Change |
|---|---|---|---|
| Revenue | $994.4 million | $914.5 million | +9% |
| Gross Profit | $665.4 million | $625.8 million | +6% |
| Gross Margin | 67% | 68% | -100 bps |
| Operating Income | $162.6 million | $115.1 million | +41% |
| Operating Margin | 16% | 13% | +300 bps |
| Net Income | $114.4 million | $106.2 million | +8% |
| Diluted EPS | $0.68 | $0.62 | +10% |
| Operating Cash Flow | $245.5 million | $149.1 million | +65% |
| Cash & Investments | $642.3 million | $586.9 million | N/A |
| Long-Term Debt | $0 | $0 | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Driven primarily by the logistics and consumer electronics sectors. A one-time revenue recognition of approximately $13 million occurred due to a strategic channel partnership in medical lab automation.
- Gross Margin Compression: Margins declined to 67% from 68%, primarily due to a $13 million charge for excess and obsolete inventory following a strategic product portfolio review under new leadership. Tariffs and less favorable industry mix also contributed.
- Operating Leverage: Operating income increased significantly (41%) despite flat net income margins, as operating expenses decreased 2% due to cost management and headcount reductions.
- Tax Impact: The effective tax rate rose to 37% from 19% due to a $33.2 million discrete tax expense related to the enactment of the "One Big Beautiful Bill Act" (OBBBA), which modified international tax provisions (NCTI/GILTI).
- Geographic Shifts: Americas revenue grew 16% and Europe 15%. Greater China revenue declined 3% due to procurement shifts by customers and export control impacts.
Guidance, Outlook, and Risks
- Strategic Initiatives: Management is executing a "salesforce transformation" to double the customer base within five years, focusing on AI-enabled, easy-to-use products. The company expects to achieve an additional $35–$40 million in annualized operating expense reductions by the end of 2026.
- Capital Allocation: The company maintains a strong balance sheet with no long-term debt. In February 2026, the Board authorized a new $500 million share repurchase program. Dividends were increased to $0.085 per share in Q4 2025.
- Key Risks:
- Supply Chain: Reliance on third-party manufacturers in Indonesia and Malaysia; potential disruptions from geopolitical tensions (China-Taiwan) affecting chip procurement.
- Geopolitics: U.S. export controls and sanctions on Chinese semiconductor companies continue to create operational challenges and potential revenue loss in Greater China.
- Leadership Transition: The company is navigating a transition to a new CEO appointed in June 2025, which carries execution risks.
- Inventory: Risk of further charges for excess or obsolete inventory as the company reduces focus on legacy products.
Investor Verification Checklist
- Inventory Valuation: Verify the sustainability of the $13 million inventory charge and assess if further write-downs are likely given the strategic shift away from legacy products.
- Tax Rate Normalization: Confirm the impact of the OBBBA legislation on future cash tax benefits versus the discrete expense recorded in 2025.
- Logistics Growth: Validate the growth trajectory in the logistics sector, which is cited as the highest-growth end market, and the success of the new SLX devices.
- China Exposure: Monitor the impact of U.S. export controls on revenue from Greater China, which declined 3% in 2025.
- Cost Reduction Execution: Track progress toward the targeted $35–$40 million in annualized operating expense reductions by end of 2026.